Vairavan Latha

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 92% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Vairavan Latha's trades of Arcutis Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-11
S Sale
61,881 +33.0%
19.10
US$2,486,161 		61,881 +33.0% 19.10 US$2,486,161
2026-05-11 2026-05-11
PrS Proposed sale
58,321
392.08
US$96,460 		58,321 392.08 US$96,460
2026-05-06 2026-05-04
S Sale
14,574 +28.1%
71.91
US$4,806,142 		14,574 +28.1% 71.91 US$4,806,142
2026-05-04 2026-05-04
PrS Proposed sale
1,341
23.61
US$31,662 		1,341 23.61 US$31,662
2026-03-03 2026-03-02
S Sale
81 -0.1%
25.91
US$2,099 		81 -0.1% 25.91 US$2,099
2026-03-03 2026-03-02
S Sale
2,772 -3.1%
25.16
US$69,745 		2,772 -3.1% 25.16 US$69,745
2026-03-02 2026-03-02
PrS Proposed sale
2,853
25.18
US$71,845 		2,853 25.18 US$71,845
2026-02-04 2026-02-02
S Sale
1,320 -2.0%
25.50
US$33,658 		1,320 -2.0% 25.50 US$33,658
2026-02-02 2026-02-02
PrS Proposed sale
1,320
25.50
US$33,658 		1,320 25.50 US$33,658
2025-11-05 2025-11-03
S Sale
88 -0.1%
24.72
US$2,175 		88 -0.1% 24.72 US$2,175
2025-11-03 2025-11-03
PrS Proposed sale
88
24.72
US$2,175 		88 24.72 US$2,175
2025-08-05 2025-08-04
S Sale
89 -0.1%
14.33
US$1,275 		89 -0.1% 14.33 US$1,275
2025-08-04 2025-08-04
PrS Proposed sale
89
14.10
US$1,255 		89 14.10 US$1,255